Apella

If you need transparent self-serve pricing or a lightweight SaaS deployment

• Apella appears to be enterprise-sold with non-public pricing, and likely requires hardware and integrations.

If your primary need is block scheduling optimization without deploying sensors

• Some scheduling-focused vendors offer optimization without ambient sensing hardware and may be better aligned for scheduling-only programs.

If your program is primarily focused on multimodal safety/quality review

• Other vendors emphasize comprehensive multimodal safety/quality capture and review workflows that may better fit that use case.

If you want a single vendor for a hospital-wide ambient platform across inpatient rooms and ORs

• Some vendors market broader smart-hospital platforms that cover multiple care areas; organizations should validate OR-specific maturity when considering such vendors.

Public information gaps (limits the buyer’s ability to validate)

• Security and compliance certifications are not clearly documented in publicly accessible sources.
• Public pricing is not available.
• Limited accessible third-party end-user review content reduces visibility into implementation experience and support quality.

Potential operational/technical limitations (category-level risks; must be validated with vendor references)

• Model generalization across OR types (specialty variation, lighting, room layout, equipment) may require per-site calibration.
• Integration complexity and ongoing interface maintenance.
• Adoption risks if staff perceive sensing as surveillance or if video retention policies are unclear.

• The vendor describes automatic capture of multiple intraoperative events and reporting those events to the EHR as a core capability.

• The vendor publishes metrics such as reductions in OR overtime minutes; these are vendor-provided claims and should be validated with customer references and pre/post analyses.

• The vendor indicates the system has been subject to independent peer review; organizations should request the citation to evaluate the peer-reviewed publication and underlying methodology.

Public customer evidence

• Tampa General Hospital press release (Aug 8, 2024) describes a deployment of Apella to support OR safety and efficiency.
  • Critical evaluation
    • A hospital press release is inherently promotional and not equivalent to an independently audited outcomes study.
    • No detailed methodology, control group, or baseline/variance data were visible in the captured announcement.

Vendor-published performance claims (treat as unverified unless independently replicated)

• The vendor publishes a claim that deployments save an average number of overtime minutes per operating room per month.
  • Critical evaluation
    • This is a vendor-published statistic; the supporting methodology and sample size were not provided in the material accessible during this research.
    • Organizations should request the underlying study design, definitions (for example, what counts as an “overtime minute”), and evidence of generalizability across specialties and staffing models.

Vendor blog referencing peer review

• The vendor states that its ambient AI was independently peer-reviewed and reports an observed increase in cases per OR in a separate analysis.
  • Critical evaluation
    • The vendor-authored blog post is a useful pointer but does not replace direct access to the underlying peer-reviewed publication. Buyers should request the publication reference and verify methodology and external validity.

• No Apella-specific Peer Insights product review page was surfaced in accessible results within this research window; Gartner often requires login and may block automated access.

• No Apella-specific TrustRadius product page surfaced in accessible results.

• A G2 page referencing Apella appeared to categorize the company in ways that may not match the perioperative operations category, which raises questions about data quality for that listing.

What the product does (core value proposition in objective terms)

• Apella is an ambient AI and computer-vision platform for perioperative/operating-room (OR) operations. It passively captures OR workflow signals (for example, surgical phases and events) and converts them into a structured intraoperative timeline; the system also reports these events back into the electronic health record (EHR) according to the vendor.
• The product emphasizes operational data derived from sensors and computer vision rather than manual timestamps, with intended uses in OR throughput, safety, staffing, scheduling and capacity planning.

Target market and market positioning

• Target buyers appear to be hospitals and health systems (perioperative leadership, OR directors, surgical services, anesthesia leadership, operational excellence teams, and hospital IT/informatics).
• Market category overlaps with OR optimization/throughput, perioperative analytics, smart OR sensing, and surgical safety/quality intelligence.

Company background (founding year, HQ, key leadership)

• Founded: 2020 (multiple company databases report 2020).
• HQ: Oakland, California (reported by company databases and state filings).
• Key leadership (publicly listed across sources)
  • David Schummers — CEO
  • Cameron Marlow — Founder & CTO
  • Jordan Tuttle — Co-Founder & CCO

Funding and growth: investment rounds, acquisitions, estimated customer count/revenue if public

• Series A: an early institutional round announced in late 2021 (vendor press release and coverage).
• Series B: third-party sources report a larger follow-on financing in early 2026; amounts and reporting vary across sources.
• Customer count / revenue
  • Not clearly disclosed publicly on Apella’s site in the pages accessible during this research; any estimates from commercial databases would be directional rather than authoritative.

Pricing model with specific tiers and costs where available

• Public, self-serve pricing was not found on Apella’s official site during this research. The product appears to be sold through enterprise procurement channels (demo/contact sales required).
• Implication: budgeting and procurement will likely require a scoped quote tied to OR count, sensor footprint, integration work, and analytics modules. Published per-seat or per-OR pricing is available directly from the vendor at contract time.

Total cost of ownership considerations (implementation, training, hidden costs)

• Likely cost drivers (inferred from the product type and vendor statements)
  • Hardware and sensing deployment in each OR (cameras/sensors, networking, mounting, facilities approvals).
  • EHR integration (interfaces, security review, potential EHR integration fees in some organizations).
  • Workflow change management (nursing, anesthesia, surgeons, service line leaders).
  • Ongoing model calibration and monitoring to maintain event-detection performance across rooms.
• Areas of caution
  • Vendors in this category often market operational gains; time-to-value can be slowed by integration approvals, room-by-room rollout logistics, and clinician acceptance.

Key competitors in the space (list 4-6 direct alternatives)

• LeanTaaS iQueue for Operating Rooms (schedule/block/open-time optimization; less focused on ambient sensing)
• Qventus (operations optimization; overlaps with scheduling-optimization tools)
• Artisight (smart hospital / ambient intelligence; offers Smart OR functionality)
• Surgical Safety Technologies (SST) OR Black Box Platform (safety/quality intelligence with multimodal capture)
• Proximie (OR connectivity and collaboration platform; overlap in OR video/feeds but a different primary use case)